Newsvine
  • Welcome
  • Help
  • Report Bug
  • Conversation Tracker
  • Your Column
  • Replies
  • Friends
Type Comments Since You Last CheckedArticle Source Last Checked Stop Tracking All Clear Tracking All
Advertise | AdChoices
Log In | Register
Close the Login Panel
Existing users log in below. New users please register for a free account.

New Users:

Existing Users:

E-Mail:
Password:
Forgot Password?
Please enter the e-mail address or domain name you registered with:
E-Mail/Domain:
Back to Login
Log Out
  • Top News
  • Local News
  • World
  • U.S.
  • Sports
  • Politics
  • Tech
  • Entertainment
  • Science
  • Business
  • Health
  • Odd News
  • More
    • Arts
    • Education
    • Environment
    • Fashion
    • History
    • Home & Garden
    • Not News
    • Religion
    • Travel
Visit Josh Rosenroth's column >>

JOSH ROSENROTH

retired natural scientist
Articles Posted: 543  Links Seeded: 1546
Member Since: 3/2010  Last Seen: 5/16/2012

What is Newsvine?

Updated continuously by citizens like you, Newsvine is an instant reflection of what the world is talking about at any given moment.

Get a Free Account
Help
Fun Stuff
  • Your Clippings
  • Leaderboard
  • E-Mail Alerts
  • Top of the Vine
  • Newsvine Live
  • Newsvine Archives
  • The Greenhouse
  • Recommended Articles
  • Wall of Vineness
Put a Seed Newsvine link on your own site

Berlin scientists develop cheap anti-malaria drug | Sci-Tech | DW.DE | 16.02.2012

Seeded on Thu Feb 23, 2012 3:36 AM EST
Read ArticleArticle Source: Deutsche Welle - World Service
health, germany, drugs, berlin, world-health-organization, malaria, west-africa, max-planck-institute, tropical-medicine, capetown-south-africa, malaria-research-group
Seeded by Josh Rosenroth
Advertise | AdChoices

Malaria kills more than a million people worldwide every year. Scientists in Berlin have developed a way to produce an effective anti-malaria drug cheaply and in large quantities by using a formerly discarded by-product.

  • Enjoy this article? Help vote it up the 'Vine.

Published to:

  • Josh Rosenroth's Column, All of Newsvine
  • Groups: Fibromyalgia friends, GermanVine, Newsvine Science
  • Regions: Berlin
  • Public Discussion (1)
Josh Rosenroth

(DW) (...) Seeberger said that the first commercial prototypes of the artemisinin production reactors should be ready to go by the end of 2012, and may be deployed early in 2013.

  • 3 votes
Reply#1 - Thu Feb 23, 2012 3:38 AM EST
Leave a Comment:
You're in Easy Mode. If you prefer, you can use XHTML Mode instead.
You're in XHTML Mode. If you prefer, you can use Easy Mode instead.
(XHTML tags allowed - a,b,blockquote,br,code,dd,dl,dt,del,em,h2,h3,h4,i,ins,li,ol,p,pre,q,strong,ul)
Newsvine Privacy Statement
As a new user, you may notice a few temporary content restrictions. Click here for more info.
FUN STUFF:
  • Leaderboard |
  • E-Mail Alerts |
  • Top of the Vine |
  • Newsvine Live |
  • Newsvine Archives |
  • The Greenhouse |
COMPANY STUFF:
  • Code of Honor |
  • Company Info |
  • Contact Us |
  • Jobs |
  • User Agreement |
  • Privacy Policy |
  • About our ads
LEGAL STUFF:
  • © 2005-2012 Newsvine, Inc. |
  • Newsvine® is a registered trademark of Newsvine, Inc. |
  • Newsvine is a property of msnbc.com